Drugmakers race to find a place in the next wave of obesity drugsDrugmakers are betting they can crack into the obesity drug market that Novo Nordisk and Eli Lilly currently dominate.{}

Drugmakers are betting they can crack into the obesity drug market that Novo Nordisk and Eli Lilly currently dominate.https://www.cnbc.com/2026/06/13/glp-1s-lilly-novo-pfizer-look-to-new-weight-loss-drugs.html